Marzena Ciechomska

Associate Professor

National Institute of Geriatrics, Rheumatology and Rehabilitation

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Marzena Ciechomska is an Associate Professor at the National Institute of Geriatrics, Rheumatology and Rehabilitation in Poland. Her research focuses on rheumatic diseases, particularly in the areas of biomarkers for rheumatoid arthritis, the effects of JAK inhibitors, and immune responses in inflammatory conditions. Recent publications include studies on thrombotic markers in rheumatoid arthritis patients and the management of fatigue through innovative therapies. She is also involved in exploring the role of miRNA in disease progression and treatment response.

Articles (12)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Jakub Wroński

National Institute of Geriatrics, Rheumatology and Rehabilitation

POLAND

View details

Włodzimierz Maśliński

Head of Department

National Institute of Geriatrics, Rheumatology and Rehabilitation

POLAND

View details

Barbara Lisowska

professor

National Institute of Geriatrics, Rheumatology and Rehabilitation

POLAND

View details

Piotr Głuszko

Professor, consultant

National Institute of Geriatrics, Rheumatology and Rehabilitation

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marzena Ciechomska

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Thrombotic Markers in Plasma as Predictors of Response in Rheumatoid Arthritis Patients Treated with Baricitinib – Pilot Observation

Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes

S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs

Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4+Foxp3+ Treg Induction

Impact of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Rheumatic Disease Patients on T Helper Cell Differentiation

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients

Effect of crystallinity and related surface properties on gene expression of primary fibroblasts

Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19

Collaborators (4)

Jakub Wroński

Włodzimierz Maśliński

Barbara Lisowska

Piotr Głuszko

Make your next move.